Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Clinical Dimensions of Bloating in Functional Gastrointestinal Disorders.

Ryu MS, Jung HK, Ryu JI, Kim JS, Kong KA.

J Neurogastroenterol Motil. 2016 Jul 30;22(3):509-16. doi: 10.5056/jnm15167.

2.

Baroreflex mechanisms in Irritable Bowel Syndrome: Part I. Traditional indices.

Davydov DM, Naliboff B, Shahabi L, Shapiro D.

Physiol Behav. 2016 Apr 1;157:102-8. doi: 10.1016/j.physbeh.2016.01.042. Epub 2016 Feb 2.

PMID:
26836276
3.

Psychological therapies in patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.

Altayar O, Sharma V, Prokop LJ, Sood A, Murad MH.

Gastroenterol Res Pract. 2015;2015:549308. doi: 10.1155/2015/549308. Epub 2015 Jan 31. Review.

4.

The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials.

Chang L, Lembo AJ, Lavins BJ, Shiff SJ, Hao X, Chickering JG, Jia XD, Currie MG, Kurtz CB, Johnston JM.

Aliment Pharmacol Ther. 2014 Dec;40(11-12):1302-12. doi: 10.1111/apt.12985. Epub 2014 Oct 13.

5.

Conditioned pain modulation in women with irritable bowel syndrome.

Jarrett ME, Shulman RJ, Cain KC, Deechakawan W, Smith LT, Richebé P, Eugenio M, Heitkemper MM.

Biol Res Nurs. 2014 Oct;16(4):368-77. doi: 10.1177/1099800413520486. Epub 2014 Jan 24.

6.

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea.

Garsed K, Chernova J, Hastings M, Lam C, Marciani L, Singh G, Henry A, Hall I, Whorwell P, Spiller R.

Gut. 2014 Oct;63(10):1617-25. doi: 10.1136/gutjnl-2013-305989. Epub 2013 Dec 12.

7.

Association between symptoms of irritable bowel syndrome and methane and hydrogen on lactulose breath test.

Lee KN, Lee OY, Koh DH, Sohn W, Lee SP, Jun DW, Lee HL, Yoon BC, Choi HS, Hahm JS.

J Korean Med Sci. 2013 Jun;28(6):901-7. doi: 10.3346/jkms.2013.28.6.901. Epub 2013 Jun 3.

8.

Acute sodium bicarbonate loading has negligible effects on resting and exercise blood pressure but causes gastrointestinal distress.

Kahle LE, Kelly PV, Eliot KA, Weiss EP.

Nutr Res. 2013 Jun;33(6):479-86. doi: 10.1016/j.nutres.2013.04.009. Epub 2013 May 17.

9.

Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.

Lackner JM, Ma CX, Keefer L, Brenner DM, Gudleski GD, Satchidanand N, Firth R, Sitrin MD, Katz L, Krasner SS, Ballou SK, Naliboff BD, Mayer EA.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1147-57. doi: 10.1016/j.cgh.2013.03.011. Epub 2013 Mar 21.

10.

Multidomain patient-reported outcomes of irritable bowel syndrome: exploring person-centered perspectives to better understand symptom severity scores.

Lackner JM, Jaccard J, Baum C.

Value Health. 2013 Jan-Feb;16(1):97-103. doi: 10.1016/j.jval.2012.08.2207. Epub 2012 Nov 30.

11.

Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome.

Wolitzky-Taylor K, Craske MG, Labus JS, Mayer EA, Naliboff BD.

Behav Res Ther. 2012 Oct;50(10):647-50. doi: 10.1016/j.brat.2012.05.010. Epub 2012 Jun 23.

12.

Subtypes and Symptomatology of Irritable Bowel Syndrome in Children and Adolescents: A School-based Survey Using Rome III Criteria.

Rajindrajith S, Devanarayana NM.

J Neurogastroenterol Motil. 2012 Jul;18(3):298-304. doi: 10.5056/jnm.2012.18.3.298. Epub 2012 Jul 10.

13.

Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air?

Lacy BE, Gabbard SL, Crowell MD.

Gastroenterol Hepatol (N Y). 2011 Nov;7(11):729-39.

14.

Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis.

Naliboff BD, Kim SE, Bolus R, Bernstein CN, Mayer EA, Chang L.

Am J Gastroenterol. 2012 Mar;107(3):451-9. doi: 10.1038/ajg.2011.377. Epub 2011 Nov 15.

15.

Patient-reported outcomes for irritable bowel syndrome are associated with patients' severity ratings of gastrointestinal symptoms and psychological factors.

Lackner J, Jaccard J, Baum C, Smith A, Krasner S, Katz L, Firth R, Raby T, Powell C.

Clin Gastroenterol Hepatol. 2011 Nov;9(11):957-964.e1. doi: 10.1016/j.cgh.2011.06.014. Epub 2011 Jun 21.

16.

A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations.

Craske MG, Wolitzky-Taylor KB, Labus J, Wu S, Frese M, Mayer EA, Naliboff BD.

Behav Res Ther. 2011 Jun;49(6-7):413-21. doi: 10.1016/j.brat.2011.04.001. Epub 2011 Apr 19.

17.

Understanding gastrointestinal distress: a framework for clinical practice.

Spiegel BM, Khanna D, Bolus R, Agarwal N, Khanna P, Chang L.

Am J Gastroenterol. 2011 Mar;106(3):380-5. doi: 10.1038/ajg.2010.383.

18.
19.

Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice.

Spiegel BM, Bolus R, Harris LA, Lucak S, Chey WD, Sayuk G, Esrailian E, Lembo A, Karsan H, Tillisch K, Talley J, Chang L.

Aliment Pharmacol Ther. 2010 Nov;32(9):1192-202. doi: 10.1111/j.1365-2036.2010.04443.x. Epub 2010 Aug 30.

20.

Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale.

Spiegel B, Bolus R, Harris LA, Lucak S, Naliboff B, Esrailian E, Chey WD, Lembo A, Karsan H, Tillisch K, Talley J, Mayer E, Chang L.

Aliment Pharmacol Ther. 2009 Dec 1;30(11-12):1159-70. doi: 10.1111/j.1365-2036.2009.04144.x. Epub 2009 Sep 12.

Items per page

Supplemental Content

Write to the Help Desk